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Nicotinic acid (NA, a.k.a. vitamin B3 or niacin) can reduce blood cholesterol and low-density lipoproteins
whereas increase high-density lipoproteins. However, when NA is used to treat dyslipidemias, it causes a
strong side effect of cutaneous vasodilation, commonly called flushing. A recent study showed that NAmay
cause flushing by lowering activation threshold temperature of the heat-sensitive capsaicin receptor TRPV1
ion channel, leading to its activation at body temperature. The finding calls into questionwhetherNAmight
also interact with the homologous heat-sensitive TRPV2–4 channels, particularly given that TRPV3 and
TRPV4 are abundantly expressed in keratinocytes of the skin where much of the flushing response occurs.
We found that NA indeed potentiated TRPV3 while inhibited TRPV2 and TRPV4. Consistent with these
gating effects, NA lowered the heat-activation threshold of TRPV3 but elevated that of TRPV4. We further
found that activity of TRPV1 was substantially prolonged by extracellular NA, which may further enhance
the direct activation effect. Consistent with the broad gating effect on TRPV1–4 channels, evidence from the
present study hints that NA may share the same activation pathway as 2-aminoethoxydiphenyl borate
(2-APB), a common agonist for these TRPV channels. These findings shed new light on the molecular
mechanism underlying NA regulation of TRPV channels.
N
icotinic acid (NA) is a water-soluble small molecule vitamin. It is the precursor for nicotinamide adenine
dinucleotide (NAD1), a coenzyme involved in the catabolism of fat. NA has been prescribed for over 50
years to lower the serum concentrations of total cholesterol as well as low-/very low-density lipoprotein
whereas raises that of high-density lipoprotein1,2. The beneficial effect is at least in part attributable to activation of
hydroxy-carboxylic acid receptor 2 (HCA2) in adipocytes, leading to a drop of intracellular cyclic adenosine
monophosphate (cAMP) level and inhibition of lipolysis3–5. However, NA treatment has a very unpleasant side
effect commonly called flushing, which is characterized by cutaneous vasodilation and symptoms of hot flashes
and burning sensation6–8. Since flushing occurs to 90% of patients taking NA, the clinical application has been
significantly limited. Indeed, about 1/3 of patients givenNAhave opted to stop the treatment7,8. One pathway that
mediates the flushing response was thought to be activation of arrestin beta 1 and the downstream effector ERK 1/
2MAP kinase 7 in Langerhans cells and keratinocytes of the skin, leading to release of vasodilatory prostaglandin
D2 and E29–12. Nonetheless, pharmacological blockade of cyclooxygenase (by aspirin) and prostaglandin D2
receptor 1 (by laropiprant) does not fully inhibit flushing13,14.
In a recent study15, we found that NA activates the capsaicin receptor TRPV1, a heat-activated polymodal
cellular sensor that mediates the flushing response upon consumption of spicy food16,17. We observed that NA
directly and potently activates TRPV1 from the intracellular side by lowering the activation threshold for heat,
causing channel activation at physiological body temperature. In support of the important role TRPV1 plays in
NA-induced flushing, we observed that NA-induced increase in blood flowwas substantially reduced inTrpv12/2
knockout mice15,18. This new finding confirms existing observations that multiple pathways mediate the flushing
response13,14,19,20, and suggests novel methods for inhibiting flushing to improve patient compliance.
TRPV1 belongs to a group of homologous heat-sensing TRPV channels including TRPV2, TRPV3, andTRPV4
that share substantial structural and functional properties such as involvements in cardiovascular functions21,22.
Like TRPV1, TRPV2–4 channels are heat sensors but exhibit distinct activation threshold temperatures22. TRPV1–
4 channels also share the common polymodal activation property. In particular, 2-Aminoethoxydiphenyl borate
(2-APB) is a common activator for TRPV1-3 and a mutant TRPV423. Our observation of NA-induced TRPV1
activation raises the question whether these TRPV1 homologs can also be targeted by NA. In the present study, we
systematically examined the responses of TRPV2–4 to both intracellular and extracellular NA. In addition, we
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studied the effect of extracellular NA on TRPV1, an important issue
given that under clinical settings the extracellular NA concentration is
expected to be higher than the intracellular NA concentration.
Results
Effects of Extracellular NA on TRPV1 Activation. Our reported
study showed that NA directly and strongly activates TRPV1 from
the intracellular side15. In contrast, no channel activation was
observed when NA was applied extracellularly. This can be seen in
Figure 1A&B (n 5 3, P , 0.005). However, when NA was added
extracellularly together with 2-APB, we observed two effects. The
efficacy of 2-APB activation was increased in the presence of NA
by 14.5 6 3.6% (n 5 3, P , 0.05; Figure 1 B&C, Table 1). More
interestingly, the deactivation process of 2-APB-induced activation
was remarkably prolonged (Figure 1 B&D).When 2-APB was applied
alone, it took 27.0 6 3.7 s (n 5 6) for the current to decrease to one-
half of its peak amplitude (time to Ihalf). When NA was co-applied
with 2-APB, the deactivation time was more than doubled (n 5 3, P
, 0.01). Increasing NA concentration also extended the deactivation
process (Figure 1B&D). The extended channel activity would
substantially intensify the flushing response caused by TRPV1
activation. Interestingly, the prolongation effect on deactivation was
completely reversible. After channels were completely closed at the
end of the elongated deactivation, applying 2-APB alone again evoked
currents with normal activation and deactivation kinetics (Figure 1B).
Hence, like intracellular NA, extracellular NA also exerts potentiat-
ing effects on TRPV1 by both promoting and prolonging channel
activation.
Effects of Intracellular NA on TRPV3.Our previous results suggest
that heat activation of TRPV1 at body temperature is likely involved
in the flushing response caused by NA15. Is TRPV1 the only ion
channel target for NA? Particularly, since the heat-sensing TRPV2-4
channels share substantial sequence homology (40–50%) and
functional properties with TRPV1, it is important to test whether
these channels can also be activated or potentiated by NA. TRPV3
is in particular attractive because it is highly expressed in keratinocytes
and it has an even lower heat activation threshold (,30uC) than
TRPV1 (,40uC)22. As shown in Figure 2A, in inside-out patches
from which 1 mM intracellular 2-APB (a saturating concentration
for TRPV3) evoked a fairly large TRPV3 current, 130 mM NA
caused only marginal channel activation at room temperature.
Quantitatively, the efficacy of NA on TRPV3 activation was only 0.6
6 0.1% (n 5 5) of that of 2-APB (Figure 2B, Table 2). Nonetheless,
when applied together, NA could substantially potentiate the
activation of TRPV3 by 2-APB (Figure 2A), increasing the efficacy
of 2-APB by 81.2 6 28.4% (n 5 5) (Figure 2B, Table 2). These
observations suggest that potentiation of TRPV3 by NA may also
contribute to the overall flushing response.
To further examine the effect of NA on TRPV3, we compared
heat-induced activation of the channel in inside-out patches in the
absence or presence of NA. In the absence of NA, raising the record-
ing temperature to near 30uC started to activate the channel, with the
activation threshold temperature quantified to be 29.42 6 0.28uC (n
5 3) (Figure 2C&D). We found that including 30 mM NA in the
heated solutionmade it much easier to activate the channel, reducing
the threshold temperature substantially to 23.69 6 1.35uC (n 5 3).
Figure 1 | Extracellular nicotinic acid dramatically delays deactivation of 2-APB-induced TRPV1 currents. (A) Representative current trace from an
on-cell recording with 130 mM NA in the pipette followed by membrane rapture, leading to whole-cell patch-clamp recording. (B) Representative
whole-cell currents induced by 2-APB and NA applied extracellularly, recorded at 180 mV (top trace) and 280 mV (bottom trace). (C) Comparison of
current amplitudes. n 5 3–6. (D) Comparison of the slowdown in the deactivation rate, quantified as the time it took for the current to decline to 50% of
the peak level. n 5 3 to 5. *, p , 0.05; **, p , 0.01; ***, p , 0.005; n.s., not significant.
www.nature.com/scientificreports
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Single-channel recordings further confirmed that as the recording
temperature approached the activation threshold temperature, chan-
nel activity started to increase (Figure 2E). This finding suggests that
NA dynamically regulates the activity of TRPV3, which may con-
tribute to the flushing response.
Effects of Intracellular NA on TRPV4. TRPV4 has similar heat-
activation profile as TRPV3, but is insensitive to 2-APB23. To
facilitate functional study, we used a TRPV4 mutant (N456H/
W737R, named TRPV4_dm) which confers 2-APB sensitivity on
TRPV424. Similar to the case for TRPV3, intracellular NA activated
TRPV4_dm to a very limited extent (Figure 3). Compared to 1 mM
2-APB (a saturating concentration for TRPV4_dm), the efficacy of
130 mM NA was only 19.2 6 0.1% (n 5 4, P , 0.005; Figure 3B,
Table 2). Therefore, TRPV4 is unlikely to be a major player in NA
triggered flushing response. Since 2-APB is not an agonist for the
wildtype TRPV4, we did not further characterize the effect of NA on
2-APB induced TRPV4_dm current.
Effects of Intracellular NA on TRPV2. TRPV2 was completely
insensitive to intracellular NA. We tested the effect of intracellular
NA on TRPV2 in two ways. First, we conducted inside-out patch
recordings with NA perfused into the bath. No activation by NA was
observed in TRPV2-expressing cells, though 4 mM extracellular 2-
Table 1 | Effects of extracellular NA on heat-sensing TRPV channels
INA/I2-APB I(NA 1 2-APB)/I2-APB Effect on tdeact
TRPV1 - 114.5 6 3.6% * (n 5 3) slow down
TRPV2 - 33.9 6 3.5% *** (n 5 8) -
TRPV3 - 103.8 6 1.2% (n 5 4) -
TRPV4_dm - 32.7 6 16.0% *** (n 5 3)1 -
[NA] 5 65 mM, [2-APB] 5 1 mM.
1130 mM NA was used for this test.
*p , 0.05;
***p , 0.005.
Figure 2 | Intracellular NA does not activate TRPV3 but potentiates its activation by 2-APB. (A) Representative current traces from inside-out
patches with NA or 2-APB or both applied intracellularly as indicated. (B) Comparison of current amplitudes. n 5 4. (C) Comparison of heat-
induced TRPV3 currents in the absence or presence of 30 mM NA. Dotted lines are fits to the leak current and channel current; arrows indicate the
activation threshold temperature. (D) Comparison of threshold temperatures. In this Box-and-whisker plot, the whisker top, box top, line inside
the box, box bottom, and whisker bottom represent the maximum, 75th percentile, median, 25th percentile, and minimum value of each pool of
conductance measurements, respectively. n 5 3. **, p , 0.01. (E) Example single-channel traces exhibit heat-dependent activation of the channel in
the absence (left) or presence (right) of 30 mM NA. Note that the single-channel current amplitude increased upon temperature increase.
www.nature.com/scientificreports
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APB (a saturating concentration for TRPV2) induced large currents
(Figure 4A). To confirm this observation, we used the whole-cell
configuration with NA added to the pipette solution. Again,
TRPV2 was completely inert to NA, but could be activated by 2-
APB (Figure 4B). Interestingly, we observed that co-application of
NA and 2-APB elicited significantly lower currents than 2-APB
alone (Figure 4 A&C, Table 2), indicating that NA inhibits 2-APB-
induced TRPV2 activation. The fact that NA inhibits 2-APB-induced
currents suggests the possibility that the two molecules may compete
for common binding sites.
Effects of extracellular NA on TRPV2–4 channels. Since intracellular
and extracellular NA have different effects on TRPV1, we examined
effects of extracellular NA on TRPV2–4 channels with whole-cell
patch-clamp recordings. Extracellular NA of high concentrations
did not have any observable potentiation effects on TRPV2
(Figure 5A), TRPV3 (Figure 6A) or TRPV4_dm (Figure 6B, left
panel). Interestingly, in contrast to a sensitization effect on 2-APB-
induced activation of TRPV1, extracellular NA dramatically reduced
the activation efficacy of 2-APB on both TRPV2 (Figure 5B) and
TRPV4_dm (Figure 6B, right panel), but had no influence on
activation of TRPV3 by 2-APB (Figure 6A) (see also Table 1).
Consistent with an inhibiting effect, the 2-APB dose-response curve
for TRPV2 was right-shifted, with the EC50 value determined by a
Hill fit (Equation 1) changed from 1.43 6 0.04 mM (n 5 4) without
NA to 2.34 6 0.17 mM (n 5 5) with 65 mM NA (Figure 5C). As
summarized in Figure 6C and Table 1, compared to 2-APB alone, co-
application of extracellular NA potentiated the activation effects of 2-
APB on TRPV1 to 114.5 6 3.6% (n 5 3), decreased the activation
effects of 2-APB on TRPV2 and TRPV4_dm to 33.9 6 3.5% (n 5 8)
and 32.7 6 16.0% (n 5 3) respectively, and had insignificant effects
on 2-APB potentiation of TRPV3 (103.8 6 1.2%, n 5 4). It is
however interesting to note that, when the concentration of 2-APB
was increased to 4 mM, the attenuation effects of extracellular NA on
TRPV2 activation was eliminated (INA 1 2-APB/I2-APB 5 102.5 6
1.0%, n 5 5, P , 0.001 compared to 1 mM 2-APB; Figure 6C),
again suggesting competition between NA and 2-APB for the same
binding sites.
Since extracellular NA inhibited TRPV4, we examined the effect of
NA on its heat activation. When 30 mM NA was included in the
heated solution, we observed that temperature-dependent activation
was substantially shifted to higher temperatures, with the activation
threshold temperature elevated from 23.27 6 0.78uC (in the absence
of NA; n 5 3) to 41.55 6 2.38uC (in the presence of NA; n 5 3)
(Figure 6D). This large gating effect on heat activation is consistent
with NA being an inhibitor for TRPV4.
Discussion
NA treatment is one of the oldest anti-dyslipidemias medications
known to reduce the risk of mortality from cardiovascular disease.
However, due to the strong and prevalent flushing side effect, its
beneficial potentials are far from being fully realized. Identifying
the molecular pathways mediating the flushing response and means
to reduce or even eliminate it will have important impacts on patient
compliance. Indeed, the flushing response (but not the beneficial
antidyslipidemic effect) exhibits tachyphylaxis properties, decreasing
substantially after continuous treatment9–11. This suggests that flush-
ing is mediated by pathway(s) distinct from the antidyslipidemic
pathway. Observations from our recent studies15,18 and the present
study suggest that the heat-sensing TRPV channels may both con-
tribute to and regulate the flushing response at physiological body
temperature. Our results thus support the notion that, under clinical
settings when NA is administrated at dosages much higher than the
normal daily intake level, this vitamin molecule hits polymodal heat-
sensing TRPV channels as unintended targets to cause the flushing
side-effect. Future clinical practice needs to includemeans to prevent
or lessen these unintended actions. These findings thus point to novel
potential approaches to reduce the flushing response.
Results from the present study also demonstrate that effects of NA
on the homologous TRPV channels are distinct depending on the
channel type and which side of the cell membrane NA is applied.
Table 2 | Effects of intracellular NA on heat-sensing TRPV channels
INA/I2-APB I(NA 1 2-APB)/I2-APB
TRPV1 135 6 5% *** (n 5 4) 120.1 6 2.3% *** (n 5 11)
TRPV2 - 19.0 6 8.5% *** (n 5 6)#
TRPV3 0.6 6 0.1% (n 5 5) 181.2 6 28.4% *** (n 5 5)1
TRPV4_dm 19.2 6 0.1% *** (n 5 4) N.D.
[NA] 5 65 mM, [2-APB] 5 1 mM.
#130 mM NA and 4 mM 2-APB were used for this test.
1130 mM NA was used for this test.
***p , 0.005.
Figure 3 | Intracellular NA barely activates TRPV4_dm.
(A) Representative current trace of TRPV4_dm from an inside-out patch
recording with NA or 2-APB applied intracellularly as indicated.
(B) Comparison of the efficacy of 130 mMNA relative to 1 mM 2-APB in
activating TRPV4_dm. n 5 4. ***, p , 0.005.
www.nature.com/scientificreports
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Figure 4 | Intracellular NA does not activate TRPV2 but strongly inhibits 2-APB-induced current. (A) A representative TRPV2 current trace from an
inside-out patch recording with NA and 2-APB applied on the intracellular side independently or jointly. (B) Representative whole-cell patch-clamp
currents of TRPV2 at 180 mV (top) and 280 mV (bottom) with 130 mM NA in the pipette solution and 4 mM 2-APB perfused extracellularly as
indicated (n 5 6). (C) Comparison of TRPV2 currents activated by 130 mM NA with or without 4 mM 2-APB. n 5 6. ***, p , 0.005.
Figure 5 | Extracellular NA does not activate TRPV2 but strongly inhibits 2-APB-induced current. (A&B) Representative whole-cell patch-clamp
currents of TRPV2 with NA and/or 2-APB applied extracellularly as indicated. (C) 2-APB dose-response curves for TRPV2 without (black) or with (red)
65 mMNA, fitted to a Hill equation with the following parameters (EC50 and slope factor): without NA, 1.43 6 0.04 mM and 4.09 6 0.5 (n 5 4); with
NA, 2.34 6 0.17 mM and 4.64 6 0.98 (n 5 3).
www.nature.com/scientificreports
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Overall, the effects on TRPV1 and TRPV3 are potentiating while
those on TRPV2 and TRPV4 are inhibitory. These differences may
be the results of distinct structural properties of these ion channels.
The atomic structure of TRPV1 has been recently revealed by a cryo-
EM study25,26, while little is known about the detailed structures of
TRPV2-4. Revealing the structural and mechanistic bases for these
functional differences in future studies may contribute to a better
understanding of this important group of cellular heat and nocicep-
tive sensors.
One intriguing observation from the present study is that extra-
cellular NA substantially delays the deactivation of TRPV1 from 2-
APB activation. How is this type of gating effects achieved at the
molecular level? The phenomenon implies that NA may stabilize
the open conformation induced by 2-APB. Through a mutual inter-
action of allostery, 2-APB would also stabilize the open conformation
induced by NA. Multiple extracellular channel structures are involved
in the TRPV1 activation gating process. For example, the binding
sites for proton and the spider toxin DkTx are located in the pore
loop25–28, which is also a critical component of the heat-activation
pathway29–34. Conformational rearrangement of the pore turret has
been observed upon heat activation of TRPV130,31. Hypothetically,
some of these activation conformational rearrangements may be sta-
bilized by NA, which causes 2-APB to be trapped in its binding sites
either directly or again through allosteric coupling, so that it takes a
much longer time to come off the channel.
Consistent observations from this study and our previous study
point to the possibility that NA may bind to some of the same
binding sites of 2-APB to activate TRPV channels. It was previously
concluded that, because there is no direct competition between NA
and capsaicin or the TRPV1 antagonist capsazepine, it is unlikely
that NA binds to the capsaicin-binding sites to activate TRPV115.
The presence of gating effects of NA on the capsaicin-insensitive
TRPV2–4 channels is also consistent with this view. Our results
suggest that NA may occupy with much lower affinity the binding
sites for 2-APB, which is also a general activator for this group of
TRPV channels. Structural resemblance between NA and 2-APB
lends further support for this idea.
In summary, clinical treatment of dyslipidemias patients usingNA
may affect the activities of heat-sensing TRPV1–4 ion channels.
Understanding the potential contribution of these effects to the
flushing response and how to lessen or prevent them may lead to
improvement of patient compliance in the beneficial and safe NA
treatment.
Methods
cDNA Constructs and Cell Transfection. Mouse TRPV1–4 cDNAs were inserted
into the mammalian expression vector pEYFP-N3. Expression of these constructs
yielded channels with an enhanced yellow fluorescence protein (eYFP) tagged to the
C-terminus. The fluorescent tag facilitated identification of positively transfected cells
and was shown to have undetectable influence on channel functions35. The mTRPV4
cDNA contained two point mutations (N456H/W737R) to introduce 2-APB
sensitivity to the channel24. This TRPV4_dm cDNA construct was kindly provided by
KeWei Wang at Peking University.
HEK293_tsA201 cells were cultured in a DMEMmedium supplemented with 10%
FBS, 2 mM L-glutamine, 1% (v/v) non-essential amino acids, at 37uC with 5% CO2.
Transient transfection was conducted using Lipofectamine 2000 (Invitrogen, Grand
Island, NY) according to the manufacturer’s instructions. For whole-cell recordings,
cells were plated onto glass coverslips coated with 0.1 mg/ml poly-D-lysine 24-to-
48 hours before recording.
Electrophysiological Recordings. Macroscopic patch clamp recordings were done
using a HEKA EPC10 amplifier driven by the PatchMaster software (HEKA,
Lambrecht, Germany). All recordings were done at room temperature. For inside-out
recordings, patch pipettes were pulled from thin-wall borosilicate glass and fire-
polished to a resistance of ,2 MV. For whole-cell recordings pipettes were pulled
from thick-wall borosilicate glass to 3–5 MV. A holding potential of 0 mV was used,
from which a 300-ms step to 180 mV followed by a 200-ms step to 280 mV was
delivered at 1-s intervals. Currents were low-pass filtered at 2.25 kHz and sampled at
Figure 6 | Extracellular NA does not activate TRPV3 or TRPV4_dm but strongly inhibits 2-APB-induced TRPV4_dm current. (A&B) Representative
whole-cell current of TRPV3 (A) or TRPV4_dm (B) with NA and/or 2-APB applied extracellularly as indicated. (C) Comparison of the potentiation or
inhibition effects of combining extracellular 65 mM NA with 2-APB (concentration as indicated) applied on different TRPV channels.
(D) Representative heat-induced TRPV4_dm activation in the absence or presence of 30 mM NA (left) and comparison of the activation threshold
temperatures (right). n 5 3. ***, p , 0.005.
www.nature.com/scientificreports
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12.5 kHz. For whole-cell recordings the capacity current was minimized by amplifier
circuitry, and the series resistance was compensated by 65–80%. Standard
symmetrical bath and pipette solutions contained 140 mM NaCl, 0.2 mM EGTA,
10 mM glucose and 15 mMHEPES (pH 7.2). Solution switching was achieved with a
rapid solution changer RSC-200 (Bio-Logic Science Instruments, Grenoble, France).
For clarity, all inside-out recordings are shown as outward currents at180 mV, while
whole-cell recordings are shown as both outward currents at 180 mV and inward
currents at 280 mV.
Temperature Control. Changes in experimental temperature was carried out by in-
line heating, as previously described29. Briefly, NA-containing solution was heated
with an SHM-828 8-line heater driven by a CL-100 temperature controller (Harvard
Apparatus). A BAT-12Microprobe Thermometer (Physitemp Instruments, Inc.) was
placed right next to the patch pipette to ensure accurate monitoring of local
temperature. Since TRPV3 activated near room temperature in the presence of NA, in
order to measure the activation threshold temperature, we first cooled the bath
solution below 20uC by placing the solution reservoir in an ice water baker. The
current-temperature relationship had two phases, a slow increase (likely reflected
temperature-dependent increase in the leak current amplitude29) followed by a rapid
takeoff phase. To quantify threshold temperature, we fitted a line to each of these two
phases and took the intersect point of these two fitting lines as the activation threshold
temperature.
Data Analysis. Dose-response relationships were determined from normalized
macroscopic current amplitudes measured at varying agonist concentrations, and
fitted to the Hill equation:
I{Imin
Imax
~
x½ n
ECn50z x½ n
ð1Þ
Where I and Imax represent the steady-state currents in the presence of an agonist at
concentration [x] and saturating concentration, respectively; Imin represents the leak
current or, in the case of dual-agonist experiments, the total current elicited in the
presence of the first agonist; EC50 represents the concentration of agonist that pro-
duces half-maximal activity; n is the Hill coefficient. Deactivation rate was quantified
by the time it took for the current to drop from its peak level by one-half.
All values are given as mean 6 SEM for the number of measurements (n).
Statistical significance was determined using the Student’s t-test.
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